Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc.

MDNYSE / NASDAQHealthcareSmall cap

$30.22+$0.28 (+0.9%)

Last close · Data as of Nov 20, 2026

Market cap
$1.8B
P/E
11.1x
EV / EBITDA
7.6x
Revenue
$1.9B
Net margin
8.6%
ROCE
12.9%

+32.9% over the last year

Pediatrix Medical Group, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
+7.6%
3M
+15.3%
6M
+34.5%
1Y
+32.9%
5Y
+17.0%

52-week range

Day change +$0.28 (+0.9%) from $30 to $30 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in MD, bought on each weekday since 2021.

News & filings

What Pediatrix Medical Group filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

StrengthReturn on equity rose from -13.0% to 19.1% between fiscal 2024 and fiscal 2025.

Concerns

No concern stands out for this company on the data on file.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.

Read moreShow less

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Sector
Healthcare
Shares outstanding
84.0M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$1.8B
P/E
11.1x
P/B
2.1x
EV / EBITDA
7.6x
EV / Sales
1.1x
P/S
1.0x
52-week high
$32.80
52-week low
$18.82

Profitability

Operating margin
12.1%
Net margin
8.6%
EBITDA margin
14.3%
ROE
19.1%
ROCE
12.9%
ROA
7.4%
Asset turnover
0.85

Growth

Revenue
$1.9B
Revenue growth, 1Y
-4.9%
Revenue CAGR, 3Y
-1.0%
Net profit growth, 1Y
-266.9%
Free cash flow
$252.6M

Solvency

Current ratio
1.66
Debt / Equity
0.73
Debt / Assets
0.28
CFO / Net profit
1.64
Cash / Market cap
20.4%

Where the revenue went

Of every $100 of FY2025 revenue, $9 was left as net income.

Pediatrix Medical Group, Inc. income statement flow, FY2025
Pediatrix Medical Group, Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$1.4B
RevenueGross profit$493.7M
Gross profitSelling, general and administrative$240.8M
Gross profitOther operating expenses$21.8M
Gross profitOperating income$231.1M
Operating incomePretax income$216.4M
Operating incomeInterest and other expense$14.7M
Pretax incomeTax and other$51.0M
Pretax incomeNet income$165.4M

Revenue and net profit

Revenue fell 4.9% in FY2025; net profit is the dashed line.

Pediatrix Medical Group, Inc. revenue and net profit by fiscal year
Pediatrix Medical Group, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$2.0B$66.3M
FY2023$2.0B-$60.4M
FY2024$2.0B-$99.1M
FY2025$1.9B$165.4M

Cash flows

FY2025: $271.1M from operations, $252.6M free after investment (dashed).

Pediatrix Medical Group, Inc. operating and free cash flow by fiscal year
Pediatrix Medical Group, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$166.9M$137.2M
FY2023$137.3M$104.0M
FY2024$206.6M$184.6M
FY2025$271.1M$252.6M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$1.9B-4.9%1Y
EBITDA
$274.2M
Net profit
$165.4M
Cash from operations
$271.1M+31.2%1Y
Free cash flow
$252.6M+36.9%1Y
Revenue CAGR, 3Y
-1.0%
Net profit CAGR, 3Y
35.6%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$1.9B$274.2M$165.4M$252.6M19.1%-4.9%-266.9%

Monthly returns

Month-by-month returns of MD across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$2.2B
Liabilities$1.4B
Equity$865.9M
Paid-in capital$947.6M
Retained earnings-$83.2M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; MD highlighted.

P/E against peers

MD trades at 11.1x earnings against a peer median of -11.4x.

  1. Pediatrix Medical Group, Inc. (this company)11.1x

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Pediatrix Medical Group, Inc.MDthis company$1.8B11.1x2.1x19.1%7.6x
Stoke Therapeutics, Inc.STOK$1.9B-272.5x5.3x-2.0%-95.4x
Pulse Biosciences, Inc.PLSE$1.9B-25.6x23.1x-90.2%-23.6x
Zymeworks Inc.ZYME$1.8B-22.8x6.9x-30.2%-22.4x
Maravai LifeSciences Holdings, Inc.MRVI$1.8B-14.1x8.7x-61.6%-13.5x
Viridian Therapeutics, Inc.VRDN$1.8B-5.3x3.1x-58.1%-4.9x
Vericel CorporationVCEL$1.8B110.3x5.1x4.7%60.3x
ANI Pharmaceuticals, Inc.ANIP$1.8B23.0x3.3x14.5%10.3x
Nuvation Bio Inc.NUVB$1.8B-8.8x5.9x-66.9%-9.0x
Peer median—-11.4x5.6x-44.1%-11.2x

Year-to-date ROI

MD since 1 January, against earlier years.

Historical volatility

MD's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Pediatrix Medical Group, Inc. operating margin by fiscal year
Pediatrix Medical Group, Inc. operating margin by fiscal year
DateOperating margin
FY202210.1%
FY20237.9%
FY20249.1%
FY202512.1%
LineFY2025
Cost of revenueCost Of Revenue$1.4B
Gross profitGross Profit$493.7M
Operating expensesOperating Expense$262.6M
Depreciation and amortisationDepreciation And Amortization In Income Statement$21.8M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$21.8M
Total expensesTotal Expenses$1.7B
Pretax incomePretax Income$216.4M

Learn while you research

Academy chapters picked for Pediatrix Medical Group, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Value InvestingA P/E of 11.1 could be a value opportunity, or a value trap. Know the difference.7 min read
  3. 03 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  4. 04 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  5. 05 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  6. 06 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →